What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Seiji Shioda spends much of his time researching Internal medicine, Endocrinology, Hypothalamus, Receptor and Neuropeptide.
His study in Internal medicine concentrates on Orexin, Orexigenic, Ghrelin, Central nervous system and Adenylate kinase.
His studies examine the connections between Adenylate kinase and genetics, as well as such issues in Cell biology, with regards to Forebrain.
The concepts of his Endocrinology study are interwoven with issues in Pituitary adenylate cyclase-activating peptide, Vasoactive intestinal peptide, Neuropeptide Y receptor and Neuroprotection.
Seiji Shioda focuses mostly in the field of Hypothalamus, narrowing it down to topics relating to Leptin receptor and, in certain cases, Nucleus.
He works mostly in the field of Receptor, limiting it down to topics relating to Signal transduction and, in certain cases, Protein kinase A.
His most cited work include:
- Nonmyelinating Schwann Cells Maintain Hematopoietic Stem Cell Hibernation in the Bone Marrow Niche (527 citations)
- Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. (432 citations)
- Ghrelin-induced food intake is mediated via the orexin pathway (397 citations)
What are the main themes of his work throughout his whole career to date?
Seiji Shioda mostly deals with Internal medicine, Endocrinology, Neuropeptide, Hypothalamus and Receptor.
As a part of the same scientific family, Seiji Shioda mostly works in the field of Endocrinology, focusing on Adenylate kinase and, on occasion, Cyclase.
His studies deal with areas such as GalP and Energy homeostasis as well as Neuropeptide.
His Hypothalamus research integrates issues from Nucleus and Axon.
His Receptor research is multidisciplinary, relying on both Molecular biology and Signal transduction.
His Molecular biology research is multidisciplinary, incorporating perspectives in Pituitary adenylate cyclase-activating peptide and In situ hybridization.
He most often published in these fields:
- Internal medicine (51.77%)
- Endocrinology (50.84%)
- Neuropeptide (16.90%)
What were the highlights of his more recent work (between 2012-2021)?
- Endocrinology (50.84%)
- Internal medicine (51.77%)
- Neuropeptide (16.90%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Endocrinology, Internal medicine, Neuropeptide, Cell biology and Receptor.
His Endocrinology study combines topics from a wide range of disciplines, such as GalP, Adenylate kinase and Galanin-like peptide.
His study involves Adipose tissue, Lipid metabolism, Triglyceride, Insulin and Lipid droplet, a branch of Internal medicine.
His research integrates issues of Brain ischemia and Gene in his study of Neuropeptide.
He has included themes like Dentate gyrus and Embryonic stem cell in his Cell biology study.
His Receptor research includes elements of Cell and Central nervous system.
Between 2012 and 2021, his most popular works were:
- Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice. (84 citations)
- Altered network topologies and hub organization in adults with autism: a resting-state fMRI study. (82 citations)
- Leptin and its receptors (60 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
His primary scientific interests are in Internal medicine, Endocrinology, Neuropeptide, Receptor and Oxidative stress.
His Internal medicine study focuses mostly on Hypothalamus, Leptin, Adenylate kinase, Knockout mouse and Neuroprotection.
His Endocrinology study combines topics in areas such as Retina and Orexin.
His work deals with themes such as GalP, Brain ischemia, Hypoxia and Catecholaminergic, which intersect with Neuropeptide.
His study in Receptor is interdisciplinary in nature, drawing from both Subventricular zone and Proteostasis.
His Oxidative stress research is multidisciplinary, incorporating perspectives in Reactive oxygen species, Kinase and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
